IRS Filing Status Impacts Medicare Premiums via IRMAA Thresholds
Understand how IRS tax filing status influences Medicare Part B and Part D premiums through IRMAA income thresholds. Learn about impact on premium calculations and filing strategies.
Understand how IRS tax filing status influences Medicare Part B and Part D premiums through IRMAA income thresholds. Learn about impact on premium calculations and filing strategies.
The Medicare Payment Advisory Commission's draft recommendations for 2027 include maintaining hospital service rates, increasing physician payments, reducing post-acute facility rates, and introducing safety-net hospital funding.
MedPAC's 2024 report finds stability in Medicare hospitals with rising service use and improved finances. Proposes $1B for hospitals serving more low-income patients and supports site-neutral payment expansion.
Explore key 2025 updates on healthcare affordability debates in Congress, CMS 2027 Medicare policy proposals, PBM reform legislation, and HHS AI strategy shaping U.S. insurance and Medicare landscapes.
Two Illinois brothers indicted for a $300 million COVID-19 testing fraud targeting Medicare, Medicaid, and private insurers with health care fraud and money laundering charges.
Medicare Part D stand-alone drug plans decline as enrollment in Medicare Advantage with drug coverage rises, reshaping market options for 2026.
The Medicare-X Choice Act aims to create a public health insurance option nation-wide, enhancing affordability, coverage, and competition amid Medicaid cuts and ACA tax credit expirations.
The Medicare Diabetes Prevention Program has enrolled less than 1% of eligible beneficiaries since 2018 due to administrative, referral, and awareness challenges despite proven effectiveness. CMS changes aim to improve access and provider reimbursement.
Medicare's outdated reimbursement system is jeopardizing rural office-based medical practices by underpaying for advanced outpatient procedures, leading to consolidation and increased healthcare costs. Proposed reforms aim to preserve independent care and improve access.
CMS expands Medicare drug price controls to 25 medications, achieving $12 billion savings with new Maximum Fair Prices starting 2026 and 2027 for chronic and cancer treatments.